LONDON (AP) — Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds ($9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment. Sales of the shingles treatment Shingrix made 167 million pounds, and the company...